1.Effects of mature rehmannia root extract on PDGF and bcl-2 in rat myocardial tissue after myocardial infarction
Yongjun HU ; Xiang PENG ; Peng WANG ; Yu ZHANG ; Jingjing RONG ; Yuna LUO ; Xin ZHONG
International Journal of Traditional Chinese Medicine 2019;41(6):592-595
Objective To observe the effect of mature rehmannia extract on platelet derived growth factor (PDGF) and b-cell lymphoma-2 (bcl-2) 2 in myocardial tissue of rats with myocardial infarction.Methods A total of 30 healthy SD rats were randomly divided into blank group,model group and rehmannia glutinosa group with 10 rats in each group.Myocardial infarction models were established in rats of model group and prepared Rehmannia glutinosa group.The rats in the prepared rehmannia glutinosa group were subcutaneously injected with the extract of the prepared Rehmannia glutinosa 4 g/kg.The rats in the blank group and the model group were subcutaneously injected with the same volume of saline.Once a day for 15 days.The cardiac function was measured by echocardiography in rats.The HE staining was used to observe the histopathological changes of myocardium.The levels of PDGF and Bcl-2 in myocardium were detected by ELISA.The levels of vascular endothelial growth factor (VEGF),basic fibroblast growth factor (BFGF) and CD34 protein were detected by immunoturbidimetry.Results Compared with the model group,the levels of LVDd,LVDs,LVEDs and LVESV in the Rehmannia glutinosa group were significantly decreased (P<0.05) and LVEF was significantly increased (P<0.05),while the levels of PDGF (0.53 ± 0.02 g/ml vs.0.35 ± 0.01 g/ml),Bcl-2 (1.04 ± 0.20 g/ml vs.0.84 ± 0.12 g/ml),VEGF (85.24 ± 12.45 pg/ml vs.65.26 ± 10.06 pg/ml),BFGF (86.27 ± 6.56 pg/ml vs.62.26 ± 4.37 pg/ml) and CD34 (102.36 ± 10.52 pg/ml vs.26.37 ± 3.94 pg/ml) in in the Rehmannia glutinosa group were significantly increased (P<0.05).Conclusions The Rehmannia glutinosa extract can improve the cardiac function of rats with myocardial infarction,Promote the formation of new blood vessels and improve myocardial damage.
2.Application of failure mode and effect analysis in low-energy X-ray radiotherapy
Yining YANG ; Song WANG ; Qingfeng LIU ; Xinyuan GONG ; Mu LI ; Nana LI ; Bo JIANG ; Yuna PENG ; Ping SHEN ; Yu ZHU ; Guangjie YUAN ; Wen SHEN
Chinese Journal of Radiation Oncology 2021;30(3):266-271
Objective:To explore the application of failure mode and effects analysis (FMEA) in low-energy X-ray intraoperative radiotherapy (IORT), analyze its potential risks in IORT, and preliminarily explore the feasibility of FMEA in optimizing IORT management and reducing the occurrence of potential risks.Methods:An FMEA working group was established by the IORT team (1 radiologist, 1 radiology physicist, 2 surgeons, and 2 nurses) to apply the FMEA methodology to conduct a systematic risk assessment. The process modules were established, the potential failure modes and causes for each module were analyzed, the severity (SR), frequency of occurrence (OR) and likelihood of detection (DR) of failure modes were scored and the risk priority number (RPN) was calculated: RPN= SR × OR × DR. The possible errors and potential clinical impact of each part of the radiotherapy process were prospectively analyzed and understood, the causes and current measures were analyzed for each failure mode and preventive measures were proposed and risk management measures were taken accordingly.Results:The IORT process was divided into 8 modules with 14 failure modes. The highest OR value was unsatisfactory target area confirmation (7 points), the highest SR value was equipment failure to discharge the beam (10 points), the highest DR value was wrong key entry after dose calculation (7 points), the highest RPN values were unsatisfactory target area confirmation (210 points) and ineffective protection of endangered organs (180 points). Weaknesses were corrected according to priorities, workflows were optimized and more effective management methods were developed.Conclusion:FMEA is an effective method of IORT management and contributes to reducing the occurrence of potential risks.
3.Study on serum S100A12 level in patients with obstructive sleep apnea hypopnea syndrome
Peng ZHANG ; Xiuhui CHENG ; Hua ZHANG ; Songyun OUYANG ; Wenlong LI ; Linqing GUO ; Chao XU ; Yuna ZU ; Yongxin WU
Chongqing Medicine 2017;46(34):4780-4782
Objective To investigate the correlation and significance of S100A12 with obstructive sleep apnea hypopnea syndrome (OSAHS).Methods Fifty-three patients with OSAHS were chosen as OSAHS group and 46 healthy volunteers were chosen as control group.The levels of S100A12 and hs-CRP in the two groups were compared,and its relationship with those of epworth (ESS),apnea hypopnea index (AHI),and minimum blood oxygen saturation (L-SpO2) were analysised.Results The scores of ESS,BMI,A HI,L-SpO2,hs-CRP and S100A12 in two groups were statistically significant (P<0.05).The severity of hs-CRP in severe OSAHS group was significantly higher than that of mild OSAHS group (P<0.05).There was no significant difference in hs-CRP between moderate OSAHS group and mild OSAHS group and severe group (P>0.05).The level of S100A12 in severe OSAHS group was significantly higher than that of moderate OSAHS group and OSAHS mild group(P<0.05).The level of S100A12 in moderate moderate group was significantly higher than that of mild group(P<0.01).hs-CRP was negatively correlated with ESS and AHI (r=0.822,0.787,P<0.01),was positively correlated with L-SpO2 (r=-0.740,P<0.01),S100A12 was positively correlated with ESS and AHI (r =0.707,P < 0.01),and negatively correlated with ESS and AHI (r =0.707,0.807,P<0.01),and negatively correlated with with L-SpO2 (r=-0.670,P<0.01).Conclusion S100A12 is associated with OSAHS.The higher the severity of OSAHS,the higher the S100A12 value,which can be used as a new predictor of cardiovascular disease risk in OSAHS patients.